| Date | Form | Description | Docs | XBRL | Pages |
| 02/06/25 | DEF 14A | Definitive proxy statements |
|
|
20 |
| 01/29/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/27/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/23/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/22/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/17/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/10/25 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
25 | |
| 01/10/25 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
41 |
Latest News & Events
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
Read More...Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
Read More...